Fundz

Obsidian Therapeutics, Inc. reported raising $32.4 Million in an initial SEC Form D filing, from an offering of $49.9 Million

RECENTLY ACQUIREDDec 08, 2017$32.4M of $49.9M raised

Amount Raised

$32.4 Million

$32.4 Million sold, per SEC Form D (first sale Dec 8, 2017)

Round Type

Venture

CambridgeBiotechnologyHealth Care

Quick answer

Obsidian Therapeutics raised $32.4 Million in a funding round, dated December 8, 2017. Obsidian Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Obsidian Therapeutics raise?
Obsidian Therapeutics raised $32.4 Million in a funding round on December 8, 2017.
What does Obsidian Therapeutics do?
Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases.
Where is Obsidian Therapeutics based and how big is it?
Obsidian Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 110 employees.
Who are the decision-makers at Obsidian Therapeutics?
Fundz holds 3 contacts at Obsidian Therapeutics, including the Director Regulatory Affairs CMC. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Obsidian Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Rezolute raised $138K (Seed) on January 11, 2018.
  • OnKure Therapeutics, Inc. raised $22M on January 8, 2018.
  • Vioguard raised $1M (Seed) on January 5, 2018.
  • GT Medical Technologies raised $1.9M on January 5, 2018.
  • Kerecis raised $112K (Pre-Seed) on January 3, 2018.
  • Aura Biosciences, Inc. raised $32M on January 3, 2018.

Who to call at Obsidian Therapeutics, and when

A new round usually means Obsidian Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Obsidian Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Obsidian Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Obsidian Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Obsidian Therapeutics

Location

1030 Massachusetts Avenue, Suite 400

Cambridge, Massachusetts, United States

About

Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s proprietary cytoDRiVE® technology provides a way to precisely control the timing and level of protein function by using FDA approved small molecules. Obsidian is headquartered in Cambridge, Mass. The Company has collaborations with Bristol Myers Squibb and Vertex Pharmaceuticals. For more information, please visit www.obsidiantx.com and follow us on LinkedIn and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Obsidian Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsTodd H., Director Regulatory Affairs CMC hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Obsidian Therapeutics's next move

See what Strategic adds

Obsidian Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.